Top Markets
Coin of the day
Roche Holding AG Roche Holding AG

Roche Holding AG

RO
Rangering i aksjer #41
Roche Holding AG is a global healthcare enterprise with dual focuses:... Roche Holding AG is a global healthcare enterprise with dual focuses: pharmaceuticals and diagnostics. The company maintains a significant presence in numerous countries, including its home base in Switzerland, alongside Germany, the United States, Austria, the Netherlands, the United Kingdom, France, Belgium, and various other international markets. Its pharmaceutical segment develops and supplies treatments for a wide spectrum of medical conditions, encompassing oncology, neuroscience, infectious diseases, immunology, cardiovascular and metabolic disorders, ophthalmology, and respiratory ailments, as well as specific therapies for anemia, dermatology, hemophilia, inflammatory and autoimmune conditions, and transplant patients. On the diagnostic front, Roche provides in vitro tests designed to identify various diseases like cancer, diabetes, COVID-19, hepatitis, and human papillomavirus, in addition to supplying crucial diagnostic instruments and reagents. The company was founded in Basel, Switzerland, in 1896.
Aksjekurs
$459.10
Sist synkronisert: 2026-09-11
Markedsverdi
$359.91B
Endring (1 dag)
0.11%
Endring (1 år)
30.72%
Land
CH
Handel Roche Holding AG (RO)

Kategori

P/B-forhold for Roche Holding AG (RO)
P/B-forhold per February 2026 TTM: 8.48
Ifølge Roche Holding AG sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/B-forhold (TTM) 8.48. Ved slutten av 2024 hadde selskapet et P/B-forhold på 6.41.
P/B-historikk for Roche Holding AG fra 2000 til 2026
P/B-forhold ved hvert års slutt
År P/B-forhold Endre
2026 (TTM) 8.48 9.67%
2025 7.73 20.57%
2024 6.41 -3.81%
2023 6.66 -19.73%
2022 8.30 -36.90%
2021 13.16 81.00%
2020 7.27 -11.43%
2019 8.21 6.51%
2018 7.71 -3.09%
2017 7.95 -4.05%
2016 8.29 -26.08%
2015 11.21 -4.17%
2014 11.70 6.82%
2013 10.95 -1.21%
2012 11.09 -0.79%
2011 11.17 -9.66%
2010 12.37 -40.30%
2009 20.72 559.54%
2008 3.14 -15.20%
2007 3.71 -21.50%
2006 4.72 -1.14%
2005 4.77 22.47%
2004 3.90 -12.22%
2003 4.44 14.35%
2002 3.88 13.00%
2001 3.44 -31.61%
2000 5.02 0.00%
P/B-forhold for lignende selskaper eller konkurrenter
Selskap P/B-forhold Forskjell i P/B-forhold Land
30.4982 259.75%
US
7.6344 -9.95%
US
-76.5033 -1,002.42%
US
8.7106 2.75%
US
6.754 -20.33%
CH